Search research articles
Contact Us
Filters
Showing results (1-10 of 148) with videos related to
Page
of 15
Sort By:
Maturitas
|
November 13, 2018
Gout - An update of aetiology, genetics, co-morbidities and management
Philip C Robinson
The Lancet. Rheumatology
|
January 26, 2024
Adherence to allopurinol in patients with gout: further insights generate further questions
Philip C Robinson
International Journal of Rheumatic Diseases
|
January 18, 2021
Gout models of care: The next step is to facilitate implementation
Philip C Robinson
Internal Medicine Journal
|
April 10, 2020
Biologic therapy for uveitis: addressing access issues is paramount
Philip C Robinson, Diana Conrad
Expert Opinion on Pharmacotherapy
|
July 20, 2018
Febuxostat for the treatment of hyperuricaemia in gout
Philip C Robinson, Nicola Dalbeth
Nature Reviews. Rheumatology
|
April 4, 2020
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
Philip C Robinson, Jinoos Yazdany
Internal Medicine Journal
|
August 7, 2019
Management of patients with gout and achievement of target serum urate levels at a tertiary rheumatology service in Australia
Mathuja Bavanendrakumar, Philip C Robinson
Expert Opinion on Pharmacotherapy
|
December 31, 2014
Advances in pharmacotherapy for the treatment of gout
Philip C Robinson, Nicola Dalbeth
Seminars in Arthritis and Rheumatism
|
December 28, 2020
A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections
Timothy McEwan, Philip C Robinson
Internal Medicine Journal
|
March 7, 2020
Author reply
Mathuja Bavanendrakumar, Philip C Robinson
Page
of 15
Search research articles
Search
Showing results (1-10 of 148) with videos related to
Sort By:
Page
of 15
Maturitas
|
November 13, 2018
Gout - An update of aetiology, genetics, co-morbidities and management
Philip C Robinson
The Lancet. Rheumatology
|
January 26, 2024
Adherence to allopurinol in patients with gout: further insights generate further questions
Philip C Robinson
International Journal of Rheumatic Diseases
|
January 18, 2021
Gout models of care: The next step is to facilitate implementation
Philip C Robinson
Internal Medicine Journal
|
April 10, 2020
Biologic therapy for uveitis: addressing access issues is paramount
Philip C Robinson, Diana Conrad
Expert Opinion on Pharmacotherapy
|
July 20, 2018
Febuxostat for the treatment of hyperuricaemia in gout
Philip C Robinson, Nicola Dalbeth
Nature Reviews. Rheumatology
|
April 4, 2020
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
Philip C Robinson, Jinoos Yazdany
Internal Medicine Journal
|
August 7, 2019
Management of patients with gout and achievement of target serum urate levels at a tertiary rheumatology service in Australia
Mathuja Bavanendrakumar, Philip C Robinson
Expert Opinion on Pharmacotherapy
|
December 31, 2014
Advances in pharmacotherapy for the treatment of gout
Philip C Robinson, Nicola Dalbeth
Seminars in Arthritis and Rheumatism
|
December 28, 2020
A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections
Timothy McEwan, Philip C Robinson
Internal Medicine Journal
|
March 7, 2020
Author reply
Mathuja Bavanendrakumar, Philip C Robinson
Page
of 15